Evaluation of the MolecuLightDX Device in the Measurement of Surface Wounds in Patients

What this Trial Is About

This research evaluates the MolecuLightDX device for measuring surface wounds in patients, comparing its accuracy to the standard ruler method. The goal is to assess how closely the device's wound measurements (area, length, and width) match expert panel reference standards. This observational study focuses on wounds such as diabetic foot ulcers, venous, arterial, and pressure ulcers in adults aged over 22 years. Participants will have their wounds measured using both the MolecuLightDX device, which captures fluorescence images, and the traditional ruler method. The device does not change the participant's usual wound care treatment. Measurements will be taken manually and automatically by the device, and the study will last up to six months to observe and compare measurement accuracy and consistency. During the study, participants will undergo wound assessments where data such as wound area, length, and width will be recorded using both methods. Researchers will monitor measurement errors and variability among users over time. Participants must be available and willing to follow study procedures for the full duration. The main outcome is the percent error in wound area measurement by the device compared to expert standards, with additional evaluation of measurement consistency.

MolecuLightDX Measurement Feature Clinical Validation